Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Sartorius Stedim Biotech Expands PAT Software Portfolio | Contract Pharma
Breaking News, Collaborations & Alliances

Sartorius Stedim Biotech Expands PAT Software Portfolio

To market Umetrics chemometrics software

Sartorius Stedim Biotech (SSB) has entered into a global sales partnership with Umetrics AB, a provider of chemometrics software for modeling and optimizing development and manufacturing processes. SSB will assume global marketing and distribution of Umetrics portfolio for the pharma and biopharma industries. Additionally, SSB will integrate Umetrics software programs as private label products into its own bioprocess portfolio and market the stand-alone solutions under both brands.
 
Stefan Schlack, senior vice president of marketing at SSB, said, “These software solutions will help our customers to better understand their cell culture processes and to identify potential for optimization and robust process control — an ideal addition to our bioprocess portfolio.”
 
“With SSB, we can gain access to substantially more customers thanks to its international reach and solid market standing in the biopharma sector. SSB’s integrated solutions for the complete biopharmaceutical process clearly create added value for our customers. I anticipate that this will considerably boost the biopharmaceutical industry’s interest in and usage of our products,” said Lars Lindstorm, general manager of Umetrics.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters